Antibody-drug conjugates (ADCs) offer a promising avenue for targeted cancer therapy, but their manufacturing process is intricate, involving challenges like handling potent payloads, maintaining consistent drug-antibody ratios (DAR), and ensuring safety and efficacy. In a webinar by Repligen, experts Zoltán Gulyás and Nigel Herbert shed light on how advanced technologies can address these hurdles. Through real-world case studies, they demonstrate how these innovations can accelerate processing time, enhance product consistency and operator safety, and drive process efficiency by providing accurate, real-time DAR measurements.
Zoltán Gulyás and Nigel Herbert, experts in the field, delve into how next-generation technologies can revolutionize ADC manufacturing. By showcasing practical examples, they illustrate how these innovations can streamline tangential flow filtration (TFF), minimize risks to both products and operators, maintain product uniformity while ensuring operator safety, and reduce turnaround time through precise DAR measurements.
The webinar emphasizes the critical role of cutting-edge technologies in advancing ADC manufacturing. By accelerating processing time, maintaining product consistency, and enhancing process efficiency, these tools not only optimize production but also elevate safety standards for both operators and end-users. Through a live Q&A session, participants have the opportunity to engage with the panelists and delve deeper into the applications and benefits of these innovative solutions.
Key Takeaways:
– Next-generation technologies in ADC manufacturing can enhance efficiency, safety, and product quality.
– Case studies demonstrate how these innovations improve processing time, maintain consistency, and drive process efficiency.
– Live Q&A sessions provide an interactive platform for further exploration of the benefits and applications of advanced ADC manufacturing technologies.
Tags: monoclonal antibodies, analytical methods, process development, filtration, biopharma, antibody-drug conjugates
Read more on genengnews.com